TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Mar 26, 2026
2 min read
81

Apple is set to overhaul its Siri voice assistant by allowing integration with rival artificial intelligence services, including Alphabet’s Gemini and Anthropic’s Claude. This strategic move is part of a significant update to its AI platform, Apple Intelligence, aiming to enhance user choice and functionality.
This development marks a pivotal change in Apple’s AI strategy as it competes with other Silicon Valley giants. The plan, reportedly part of a future iOS update, will allow users to route their queries through their preferred AI chatbot installed from the App Store, moving beyond the current partnership with ChatGPT.
By opening up its ecosystem, Apple could create new revenue opportunities. The company may take a commission from subscriptions to third-party AI services sold through its App Store. This positions the iPhone as a central platform for AI interaction, potentially boosting service-related income and increasing its competitive edge.
Apple is expected to announce these new software features at its Worldwide Developers Conference in June. The market will be closely watching how this integration affects user experience and Apple's position in the rapidly evolving AI landscape.
Q: Which AI services will integrate with Siri?
A: Apple plans to allow integrations with services like Google's Gemini and Anthropic's Claude, in addition to its partnership with ChatGPT.
Q: When will this feature be released?
A: The new features are expected to be previewed at Apple's Worldwide Developers Conference in June as part of a future software update.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

27 Mar 2026
Kailera Therapeutics Files for Nasdaq IPO

27 Mar 2026
US Stocks Fall; Dow Jones Hits 6-Month Low